Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 3508569, 9 pages
https://doi.org/10.1155/2017/3508569
Research Article

Thunbergia laurifolia Exhibits Antifibrotic Effects in Human Hepatic Stellate Cells

1Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
2Graduate School, Chiang Mai University, Chiang Mai, Thailand
3Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand

Correspondence should be addressed to Saranyapin Potikanond; ht.ca.umc@p.nipaynaras

Received 22 August 2017; Accepted 13 November 2017; Published 13 December 2017

Academic Editor: Luciana Dini

Copyright © 2017 Ratchadaporn Namsen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Bataller and D. A. Brenner, “Hepatic stellate cells as a target for the treatment of liver fibrosis,” Seminars in Liver Disease, vol. 21, no. 3, pp. 437–451, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. J. P. Iredale, “Hepatic stellate cell behavior during resolution of liver injury,” Seminars in Liver Disease, vol. 21, no. 3, pp. 427–436, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Carpino, A. Franchitto, S. Morini, S. G. Corradini, M. Merli, and E. Gaudio, “Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study,” Italian Journal of Anatomy and Embryology, vol. 109, no. 4, pp. 225–238, 2004. View at Google Scholar · View at Scopus
  4. R. Bataller and D. A. Brenner, “Liver fibrosis,” The Journal of Clinical Investigation, vol. 115, no. 2, pp. 209–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. A. Mokdad, A. D. Lopez, S. Shahraz, R. Lozano, A. H. Mokdad, J. Stanaway et al., “Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis,” BMC Medicine, vol. 12, article 145, 2014. View at Publisher · View at Google Scholar
  6. C. Yin, K. J. Evason, K. Asahina, and D. Y. R. Stainier, “Hepatic stellate cells in liver development, regeneration, and cancer,” The Journal of Clinical Investigation, vol. 123, no. 5, pp. 1902–1910, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Akpolat, S. Yahsi, A. Godekmerdan, M. Yalniz, and K. Demirbag, “The value of α-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study,” Histopathology, vol. 47, no. 3, pp. 276–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Hinz, G. Celetta, J. J. Tomasek, G. Gabbiani, and C. Chaponnier, “Alpha-smooth muscle actin expression upregulates fibroblast contractile activity,” Molecular Biology of the Cell (MBoC), vol. 12, no. 9, pp. 2730–2741, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. K. K. Kharbanda, D. D. Rogers, T. A. Wyatt, M. F. Sorrell, and D. J. Tuma, “Transforming growth factor-β induces contraction of activated hepatic stellate cells,” Journal of Hepatology, vol. 41, no. 1, pp. 60–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. Gressner, R. Weiskirchen, K. Breitkopf, and S. Dooley, “Roles of TGF-beta in hepatic fibrosis,” Frontiers in Bioscience, vol. 7, pp. d793–d807, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Dooley and P. Ten Dijke, “TGF-β in progression of liver disease,” Cell and Tissue Research, vol. 347, no. 1, pp. 245–256, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. L. R. Gomes, L. F. Terra, R. A. M. Wailemann, L. Labriola, and M. C. Sogayar, “TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells,” BMC Cancer, vol. 12, article 26, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. D. C. LeBert, J. M. Squirrell, J. Rindy et al., “Matrix metalloproteinase 9 modulates collagen matrices and wound repair,” Development, vol. 142, no. 12, pp. 2136–2146, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Wang, F. Lafdil, L. Wang, S. Yin, D. Feng, and B. Gao, “Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: Involvement of hepatocyte STAT3 in TIMP-1 production,” Cell & Bioscience, vol. 1, no. 1, article 140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Xie, R. Liao, L. Pan, K. Fan, C. Peng, and C. Du, “Hepatic stellate cell conditioned medium induces proliferation and epithelial-mesenchymal transition via activating ERK1/2 signaling pathway in hepatoma cells,” Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, vol. 33, pp. 210–214, 2017. View at Google Scholar
  16. F. Y. Ma, M. Sachchithananthan, R. S. Flanc, and D. J. Nikolic-Paterson, “Mitogen activated protein kinases in renal fibrosis,” Frontiers in Bioscience, vol. 1, no. 1, pp. 171–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. H. L. Reeves, C. L. Dack, M. Peak, A. D. Burt, and C. P. Day, “Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture,” Journal of Hepatology, vol. 32, no. 3, pp. 465–472, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Junsi and S. Siripongvutikorn, “Thunbergia laurifolia, a traditional herbal tea of Thailand: Botanical, chemical composition, biological properties and processing influence,” International Food Research Journal, vol. 23, no. 3, pp. 923–927, 2016. View at Google Scholar · View at Scopus
  19. W. Boonyarikpunchai, S. Sukrong, and P. Towiwat, “Antinociceptive and anti-inflammatory effects of rosmarinic acid isolated from Thunbergia laurifolia Lindl.,” Pharmacology Biochemistry & Behavior, vol. 124, pp. 67–73, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Pramyothin, H. Chirdchupunsare, A. Rungsipipat, and C. Chaichantipyuth, “Hepatoprotective activity of Thunbergia laurifolia Linn extract in rats treated with ethanol: In vitro and in vivo studies,” Journal of Ethnopharmacology, vol. 102, no. 3, pp. 408–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Aritajat, S. Wutteerapol, and K. Saenphet, “Anti-diabetic effect of Thunbergia laurifolia Linn. aqueous extract,” The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 35, pp. 53–58, 2004. View at Google Scholar · View at Scopus
  22. E. Chan and Y. Lim, “Antioxidant activity of Thunbergia laurifolia tea,” Journal of Tropical Forest Science, vol. 18, p. 130, 2006. View at Google Scholar
  23. A. Rocejanasaroj, T. Tencomnao, and W. Sangkitikomol, “Thunbergia laurifolia extract minimizes the adverse effects of toxicants by regulating P-glycoprotein activity, CYP450, and lipid metabolism gene expression in HepG2 cells,” Genetics and Molecular Research, vol. 13, no. 1, pp. 205–219, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Casini, M. Pinzani, S. Milani et al., “Regulation of extracellular matrix synthesis by transforming growth factor β1 in human fat-storing cells,” Gastroenterology, vol. 105, no. 1, pp. 245–253, 1993. View at Publisher · View at Google Scholar · View at Scopus
  25. E. R. Tamm, A. Siegner, A. Baur, and E. Lütjen-Drecoll, “Transforming growth factor-β1 induces α-smooth muscle-actin expression in cultured human and monkey trabecular meshwork,” Experimental Eye Research, vol. 62, no. 4, pp. 389–397, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Xu, A. Y. Hui, E. Albanis et al., “Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis,” Gut, vol. 54, no. 1, pp. 142–151, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Desmouliere, A. Geinoz, F. Gabbiani, and G. Gabbiani, “Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts,” The Journal of Cell Biology, vol. 122, no. 1, pp. 103–111, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Sebe, S.-K. Leivonen, A. Fintha et al., “Transforming growth factor-β-induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38β mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial-myofibroblast transdifferentiation,” Nephrology Dialysis Transplantation , vol. 23, no. 5, pp. 1537–1545, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. Y.-P. Han, C. Yan, L. Zhou, L. Qin, and H. Tsukamoto, “A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix,” The Journal of Biological Chemistry, vol. 282, no. 17, pp. 12928–12939, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Duval, J. E. Moreno-Cuevas, M. T. González-Garza, C. Maldonado-Bernal, and D. E. Cruz-Vega, “Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response,” International Journal of Inflammation, vol. 2015, Article ID 943497, 14 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Hernandez-Gea and S. L. Friedman, “Pathogenesis of liver fibrosis,” Annual Review of Pathology: Mechanisms of Disease, vol. 6, pp. 425–456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. O. Skalli, P. Ropraz, A. Trzeciak, G. Benzonana, D. Gillessen, and G. Gabbiani, “A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation,” The Journal of Cell Biology, vol. 103, no. 6, pp. 2787–2796, 1986. View at Publisher · View at Google Scholar · View at Scopus
  33. M. L. Hautekeete and A. Geerts, “The hepatic stellate (Ito) cell: Its role in human liver disease,” Virchows Archiv, vol. 430, no. 3, pp. 195–207, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Nouchi, Y. Tanaka, T. Tsukada, C. Sato, and F. Marumo, “Appearance of α-smooth-muscle-actin-positive cells in hepatic fibrosis,” Journal of Liver, vol. 11, no. 2, pp. 100–105, 1991. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Schmitt-Gräff, S. Krüger, F. Bochard, G. Gabbiani, and H. Denk, “Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers,” The American Journal of Pathology, vol. 138, no. 5, pp. 1233–1242, 1991. View at Google Scholar · View at Scopus
  36. R. C. Benyon, J. P. Iredale, S. Goddard, P. J. Winwood, and M. J. P. Arthur, “Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver,” Gastroenterology, vol. 110, no. 3, pp. 821–831, 1996. View at Publisher · View at Google Scholar · View at Scopus
  37. J. P. Iredale, R. C. Benyon, M. J. P. Arthur et al., “Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis,” Hepatology, vol. 24, no. 1, pp. 176–184, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. H. I. Fallatah, “Noninvasive biomarkers of liver fibrosis: an overview,” Advances in Hepatology, vol. 2014, Article ID 357287, 15 pages, 2014. View at Publisher · View at Google Scholar